Sage Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Sage Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Sage Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sage Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $600k | 28k | 21.67 |
| 2023-09-30 | $570k | 28k | 20.58 |
| 2023-06-30 | $1.3M | 28k | 47.02 |
| 2023-03-31 | $1.1M | 27k | 41.96 |
| 2022-12-31 | $1.0M | 27k | 38.14 |
| 2022-09-30 | $1.1M | 27k | 39.15 |
| 2022-06-30 | $876k | 27k | 32.30 |
| 2022-03-31 | $34k | 1.0k | 33.10 |
| 2021-09-30 | $45k | 1.0k | 44.07 |
| 2021-03-31 | $72k | 959 | 75.08 |
| 2019-03-31 | $11k | 67 | 164.18 |
| 2018-12-31 | $6.0k | 62 | 96.77 |
| 2018-09-30 | $9.0k | 63 | 142.86 |
| 2018-03-31 | $3.0M | 19k | 161.06 |
| 2017-12-31 | $2.8M | 17k | 164.69 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors